Target Vessel Binary Re-stenosis following the Use of Paclitaxel Coated Versus Uncoated Devices during Infrainguinal Endovascular Revascularisation of Symptomatic Peripheral Arterial Disease: Exploratory Data from the SWEDEPAD 1 and 2 Trials
Year: 2026
Type: article
Abstract: The multicentric, registry based SWEDEPAD randomised controlled trials (RCTs, NCT02051088) were designed to determine the effect of paclitaxel coated vs. uncoated devices on key clinical outcomes in patients with peripheral artery disease (PAD) undergoing infrainguinal revascularisation. In summary, the SWEDEPAD-1 and 2 trials found no benefit of paclitaxel coated devices in the primary outcomes of ipsilateral amputation for patients with chronic limb threatening ischaemia (CLTI, SWEDEPAD-1)1 or in quality of life of patients with intermittent claudication (SWEDEPAD-2).
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,000
OpenAlex ID: W7141073761
